Background: Rectal gastrointestinal stromal tumours (GISTs) have many treatment options,
but uncertainty remains regarding the best treatment regimen for this rare pathology. The …

Abstract Background British Sarcoma Group guidelines for the management of GIST were
initially informed by those published by the European Society of Clinical Oncology. This …

Background Mutation screening for gastrointestinal stromal tumor (GIST) is crucial and the c
kit gene (KIT) exon 11 mutation is the most common type. This study aimed to explore the …

Background: Significant survival benefit of adjuvant imatinib therapy has been observed in
gastrointestinal stromal tumor (GIST). However, the impact of neoadjuvant imatinib on …

Background To date, several studies have compared the surgical and oncological outcomes
of local excision (LE) and radical excision (RE) for rectal gastrointestinal stromal tumors …

Abstract Background and Objectives This study aimed to compare outcomes between
neoadjuvant imatinib and upfront surgery in patients with localized rectal gastrointestinal …

Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumor of the
gastrointestinal tract, with an annual incidence of 10–15 cases per million. However, rectal …

Background The most common curative treatment for gastrointestinal stromal tumors (GISTs)
is local excision. For rectal GISTs, however, local excision is difficult because of the …

Radical surgical treatment remains the basic method of treatment of patients with localized
resectable gastrointestinal stromal tumors (GIST), which allows achieving a permanent …

Background Rectal gastrointestinal stromal tumors (GISTs) are rare digestive tumors. The
treatment methods of rectal GISTs are diverse, while no standardized treatment was …